LEADER 03845nam 22006495 450 001 9910502646403321 005 20260114141502.0 010 $a3-030-76263-7 024 7 $a10.1007/978-3-030-76263-6 035 $a(CKB)5360000000049929 035 $a(MiAaPQ)EBC6745523 035 $a(Au-PeEL)EBL6745523 035 $a(OCoLC)1273980289 035 $a(PPN)258300205 035 $a(DE-He213)978-3-030-76263-6 035 $a(EXLCZ)995360000000049929 100 $a20211005d2021 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCancer Nanotheranostics $eVolume 2 /$fedited by Muthupandian Saravanan, Hamed Barabadi 205 $a1st ed. 2021. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021. 215 $a1 online resource (379 pages) $cillustrations 225 1 $aNanotechnology in the Life Sciences,$x2523-8035 311 08$a3-030-76262-9 320 $aIncludes bibliographical references. 327 $aPreface -- Nanotheranostics -- Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics -- Nano-Oncology -- Cancer-Targeted Nanotheranostics -- Nanotheranostics -- Cancer Nano-Immunotherapy -- Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics -- Nanoparticle for Photoresponsive Minimal-Invasive Cancer Therapy -- Biologically Synthesized Plant-Derived Nanomedicines and their In-Vitro In-Vivo Toxicity Studies in Various Cancer Therapeutics -- Nanoerythrosome -- Role of Artificial Intelligence in Cancer Nanotheranostics -- Limitations of Current Cancer Nanotheranositcs -- Safety of nanobiomaterials for Cancer Nanotheranostics -- Index. 330 $aCancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows. In the first volume of Cancer Nanotheranostics, we discussed the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies. This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics. Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research. 410 0$aNanotechnology in the Life Sciences,$x2523-8035 606 $aCancer 606 $aNanomedicine 606 $aNanobiotechnology 606 $aCancer Nanotechnology 606 $aCancer Biology 606 $aNanobiotechnology 606 $aCāncer$2thub 608 $aLlibres electrōnics$2thub 615 0$aCancer. 615 0$aNanomedicine. 615 0$aNanobiotechnology. 615 14$aCancer Nanotechnology. 615 24$aCancer Biology. 615 24$aNanobiotechnology. 615 7$aCāncer 676 $a616.9940072 700 $aSaravanan$b Muthupandian$01072527 702 $aBarabadi$b Hamed 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910502646403321 996 $aCancer Nanotheranostics$92568812 997 $aUNINA